<i>RIPK1</i> Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in MiceDenuja Karunakaran, Katey J. Rayner, Michèle Geoffrion et al.|Circulation|2020Cited by 233